Fatty Acid Binding Proteins Facilitate Reprogramming of Müller Glia into Progenitor Cells by Campbell, Warren
 
Fatty Acid Binding Proteins Facilitate Reprogramming of Müller Glia into Progenitor Cells 
Warren Campbell, Sydney Blum, Maddie Hathoot, 
Thanh Hoang2, Seth Blackshaw2, Andy J. Fischer1* 
Abstract 
Degenerative retinal diseases result in neuronal cell death, which causes in permanent vision loss 
in humans. The response to the loss of retinal neuron across species is diverse, with some species 
capable of complete and functional retinal regeneration. One source of these regenerated neurons 
is Müller glia (MG), the primary glial cell of the retina. In zebrafish, MG respond to damage by 
dedifferentiating into progenitor cells (MGPCs) which proliferate before they undergo 
neurogenesis. While mice completely lack a regenerative response by MG, chick MG form 
progenitors with limited neurogenesis, proving to be an effective phenotype for understanding 
molecular pathways that influence reprogramming and cell fate. Preliminary data has indicated 
that fatty acid binding protein 8 (FABP8) is highly upregulated early in the regenerative response 
to damage in the chick retina. FABPs are a class of lipid binding proteins that traffic 
polyunsaturated fatty acids such as docosahexaenoic acid and arachidonic acid which have been 
collectively implicated in signal transduction, neurotransmission, proliferation, differentiation, and 
neuronal migration. We hypothesize that FABP8 is significantly influencing the early 
reprogramming phase of MG, and can be utilized to drive the formation of MGPCs in 
mammalian retinas. To test this hypothesis, we will first characterize the spatiotemporal 
expression pattern of FABP8 in damaged and growth factor treated chick retinas. Subsequently, 
we will test the effect of new and established pharmacological inhibitors of FABP proteins on the 
formation of retinal progenitors in chick. Single cell sequencing identified FABP5, FABP7, and 
FABP8 as significantly increasing in Müller glia after NMDA damage. FABP8 mRNA expression 
correlated to protein localization in Müller glia after damage. Pan inhibitor of FABPs BMS309403 
was found to significantly reduce the formation of progenitor cells. Further research into the 
potential role of endocannabinoids and FABPs is being evaluated in the mechanism of action for 
affecting Müller glia’s reprogramming response. 
  
A. Introduction 
dRetinal disease is the most common cause of blindness in children, and is the most common cause 
of irreversible adult blindness in the Western world.1,2 Vision is perceived to be the most important 
sense for daily life, and there are over 25 million adults in the United States living with visual 
impairment leading to economic burden of over $180 billion.3,4 The decrease in visual acuity in 
retinal disease is due to the loss of retinal neurons. Currently there are no therapeutics available to 
restore lost retinal neurons, only prophylactic treatment to delay neuronal death in diseases such 
as diabetic retinopathy and glaucoma. Vision research has focused on therapeutic strategies to 
restore neuronal populations through endogenous mechanisms of regeneration, such as Müller glia 
(MG) reprogramming. 
MG are the primary glial cell of the retina that serves pleiotropic functions including 
neurotransmitter recycling, osmotic balance, 
structural support, potassium siphoning, and 
bicarbonate transport.5 Importantly, MG retain 
stem cell properties and are capable of replacing 
lost neurons. However, this regenerative potential 
is variable among species (Figure 1). Zebrafish can 
regenerate all retinal neurons, while mice fail to 
form any Müller glia derived progenitor cells 
(MGPCs). Chick retinas exhibit an intermediate 
phenotype with significant MGPC formation but 
limited neurogenesis into a few neuronal subtypes. 
The limited regenerative potential in chicks serves as an exemplary in-vivo model to determine 
inhibitory and potentiating factors of regeneration. 
For MG derived neuronal replacement to occur, MG must proceed through four phases: de-
differentiation, proliferation, neurogenesis, and integration.  In zebrafish, the cellular pathways 
that drive the initial de-differentiation reprogramming mechanism include Mapk-ERK, Gsk3β-β 
catenin, and Jak-stat. Similarly, factors such as let-7, TGFβ, and insulinoma-associated 1a(Insm1a) 
drives progenitors out of the cell cycle for subsequent neurogenesis.6 Many of these important cell 
signaling cascades can be recapitulated in chick models of retinal damage to induce greater MGPC 
formation and modulate neurogenesis.7–11 
These results imply that regenerative mechanisms are conserved, and with proper modulation of 
murine MG, can be induced to regenerate retinal neurons. And indeed, recent research using a 
ASCL1a overexpression model can form a few MGPCs when driven in conjunction with retinal 
damage.12 Nonetheless, this approach only produces a few MGPCs, requires damage, and only 
form bipolar cells. To further enhance the regenerative potential of murine MG, our lab and 
collaborators have conducted extensive research into the transcriptomic and epigenetic landscape 
through single cell RNA sequencing (scRNA-seq), assay for transposase accessible chromatin 
(ATAC)-sequencing, and chromatin immunoprecipitation (CHIP) sequencing.13 Utilizing these 
techniques on the developing and damaged retina, our research focus is on identifying important 
biological targets to influence MGPC formation and neurogenesis with greater efficacy. 
One target identified by this research has been the fatty acid binding proteins (FABPs). The FABPs 
are a class of intracellular lipid-binding proteins that possess a highly conserved tertiary 
structure.14 Additionally, each of these FABPs proteins are conserved among species from 
drosophila melanogaster and Caenorhabditis elegans, to mouse and human.15 FABPs contain a 
hydrophobic binding pocket capable of binding to polyunsaturated fatty acids (PUFAs) and other 
hydrophobic ligands. In the mammalian system, FABP3, 5, and 7 have been characterized by their 
expression in the brain, retina, and radial glia differentiation and their role in fate determination.16–
18 The importance of FABPs in development is hypothesized to be a result of its ability to bind to 
PUFAs including arachidonic acid and docosahexaenoic acid which have been established to 
modulate signal transduction, neurotransmission, proliferation, differentiation, and neuronal 
migration.19–22 Additionally, evidence of the proliferative functions of FABP proteins has been 
identified in aggressive cancers, including CNS malignancies.23–25 However, there has not been a 
strong scientific consensus, with additional research implicating the role of CNS FABP expression 
to include modulation of cannabinoid signaling, Peroxisome proliferator-activated receptor 
(PPAR), NF-kB, and CREB signaling.21,22,26,27 
Interestingly, FABP8 has very low levels of expression in the central nervous system (CNS) in 
mammals, but does have a high level of expression in the peripheral nervous system, specifically 
in the myelin sheaths. Currently, the specific function of this isoform is not well characterized. In 
zebrafish, knockdown of FABP8 affected the development of motor neurons causing a failure of 
axonal outgrowth from the notochord.28 Our lab has found that in the retinas of chicks, FABP8 is 
significantly overexpressed in MG in the context of retinal damage or growth factor stimulation. 
While there are other FABP proteins expressed in the chick retina, this homolog is specific to early 
phase reprogramming of MG. Hence, our preliminary data has led us to the hypothesis that FABP8 
plays a critical role in early reprogramming and de-differentiation of Müller glia that has 
the potential to significantly enhance MGPC formation in other vertebrate species. 
FABP8 is a novel target in the field of retinal regeneration and requires thorough characterization 
using pharmacologic and genetic manipulation in chick models (Aim1). Implementing MG 
FABP8 ectopic expression in an Ascl1 overexpression mouse line has not been previously 
attempted and can elucidate their impact on murine retinal regeneration models (Aim 2). When 
FABP8 expression is modulated, retrospective analysis of the cell signaling cascades and 
transcription factors to further understand subcellular FABP function in a neurological context 
(Aim 3). The findings of this research will be significant in the field of retinal regeneration by 
validating FABP8 as a target to influence regeneration, the mechanism by which they 
influence glial cellular biology, and importance of FABP proteins in neurodevelopment and 
stem cell biology. 
Methods and Materials 
Animals: 
The animals approved for use in these experiments was in accordance with the guidelines 
established by the National Institutes of Health and IACUC at The Ohio State University. Newly 
hatched P0 wildtype leghorn chicks (Gallus gallus domesticus) were obtained from Meyer 
Hatchery (Polk, Ohio). Post-hatch chicks were maintained in a regular diurnal cycle of 12 hours 
light, 12 hours dark (8:00 AM-8:00 PM). Chicks were housed in stainless-steel brooders with 
enrichment at 25o C and received water and Puranam chick starter food and supplement ad libitum.  
 Fertilized eggs were obtained from the Michigan State University, Department of Animal 
Science. Eggs were incubated at a constant 37.5°C, with a 1hr period room temperature cool down 
every 24hrs. Additionally, the eggs were rocked every 45 minutes, and held at a constant relative 
humidity of 45%. Embryos were harvested at various time points after incubation and staged 
according to guidelines established by Hamburger and Hamilton (1951). 
Intraocular injections: 
Chicks were anesthetized with 2.5% isoflurane mixed with oxygen from a non-rebreathing 
vaporizer. The technical procedures for intraocular injections were performed as previously 
described 29. With all injection paradigms, both pharmacological and vehicle treatments were 
administered to the right and left eye respectively. Compounds were injected in 20 l sterile saline 
with 0.05 mg/ml bovine serum albumin added as a carrier. Compounds included: NMDA 
(38.5nmol or 154 µg/dose; Sigma-Aldrich), FGF2 (250 ng/dose; R&D systems), purified mouse 
midkine (1 µg/dose; MyBioSource), recombinant chicken midkine (1 µg/dose, MyBioSource), 
insulin (1µg/dose; Sigma), Sodium Orthovanadate (NA3VO4, Sigma-Aldrich), and IPA-3 (Tocris 
Bioscience).  5-Ethynyl-2´-deoxyuridine (EdU) was intravitreally injected to label the nuclei of 
proliferating cells. Injection paradigms are included in each figure. 
Single Cell RNA sequencing of embryonic and mature chick retinas 
Retinas were obtained from embryonic and postnatal chicks. Embryonic retinas were harvested 
E5, E8, E12, and E15. Isolated retinas tissue were dissociated in a 0.25% papain solution in Hank’s 
balanced salt solution (HBSS), pH = 7.4, for 30 minutes, and suspensions were frequently 
triturated. The dissociated cells were passed through a sterile 70µm filter to remove large 
particulate debris. Dissociated cells were assessed for viability (Countess II; Invitrogen) and cell-
density diluted to 700 cell/µl. Each single cell cDNA library was prepared for a target of 10,000 
cells per sample (n = 2 per sample). The cell suspension and Chromium Single Cell 3’ V2 reagents 
(10X Genomics) were loaded onto chips to capture individual cells with individual gel beads in 
emulsion (GEMs) using 10X Chromium Controller. cDNA and library amplification for an optimal 
signal was 12 and 10 cycles respectively. Sequencing was conducted on Illumina HiSeq2500 
(Genomics Resource Core Facility, John’s Hopkins University) or HiSeq4000 (Novogene) with 
26 bp for Read 1 and 98 bp for Read 2. Fasta sequence files were de-multiplexed, aligned, and 
annotated using the chick ENSMBL database (Chick-5.0, Ensembl release 94) and Cell Ranger 
software. Gene expression was counted using unique molecular identifier bar codes, and gene-cell 
matrices were constructed. Using Seurat toolkits, t-distributed stochastic neighbor embedding 
(tSNE) plots or Uniform Manifold Approximation and Projection for Dimension Reduction 
(UMAP) plots were generated from aggregates of multiple scRNA-seq libraries 30,31. Compiled in 
each tSNE/UMAP plot of individual retinal cells are two sequencing library replicates for each 
embryonic stage, saline treated, and 24 hrs, 48 hrs, and 72 hrs after NMDA damage. Identification 
of different types of retinal cells that were clustered together in tSNE/UMAP plots was 
accomplished by probing for well-established cell-distinguishing genes.  Seurat was used to 
construct violin/scatter plots. Significance of difference in violin/scatter plots was determined 
using a Wilcoxon Rank Sum test with Bonferroni correction. Monocle was used to construct 
unbiased pseudo-time trajectories and scatter plotters for Müller glia and MGPCs across 
pseudotime 32–34. Genes that were used to identify different types of retinal cells included the 
following: (1) Müller glia: GLUL, VIM, SCL1A3, RLBP1, (2) MGPCs: PCNA, CDK1, TOP2A, 
ASCL1, (3) microglia: C1QA, C1QB, CCL4, CSF1R, TMEM22, (4) ganglion cells: THY1, 
POU4F2, RBPMS2, NEFL, NEFM, (5) amacrine cells: GAD67, CALB2, TFAP2A, (6) horizontal 
cells: PROX1, CALB2, NTRK1, (7) bipolar cells: VSX1, OTX2, GRIK1, GABRA1, and (7) cone 
photoreceptors: CALB1, GNAT2, OPN1LW, and (8) rod photoreceptors: RHO, NR2E3, ARR3. 
The Müller glia have an over-abundant representation in the scRNA-seq databases. This likely 
resulted from fortuitous capture-bias and/or tolerance of the Müller glia to the dissociation process. 
scRNA-seq libraries are available at: https://proteinpaint.stjude.org/F/2019.retina.scRNA.html 
Fixation, sectioning and immunocytochemistry: 
Retinal tissue samples were formaldehyde fixed, sectioned, and labeled via immunohistochemistry 
as described previously 35,36. Antibody dilutions and commercial sources for images used in this 
study are described in table 2. Observed labeling was not due to off-target labeling of secondary 
antibodies or tissue autofluorescence because sections incubated exclusively with secondary 
antibodies were devoid of fluorescence. Secondary antibodies utilized include donkey-anti-goat-
Alexa488/568, goat-anti-rabbit-Alexa488/568/647, goat-anti-mouse-Alexa488/568/647, goat-
anti-rat-Alexa488 (Life Technologies) diluted to 1:1000 in PBS and 0.2% Triton X-100. 
Labeling for EdU: 
For the detection of nuclei that incorporated EdU, immunolabeled sections were fixed in 4% 
formaldehyde in 0.1M PBS pH 7.4 for 5 minutes at room temperature. Samples were washed for 
5 minutes with PBS, permeabilized with 0.5% Triton X-100 in PBS for 1 minute at room 
temperature and washed twice for 5 minutes in PBS. Sections were incubated for 30 minutes at 
room temperature in a buffer consisting of 100 mM Tris, 8 mM CuSO4, and 100 mM ascorbic 
acid in dH2O. The Alexa Fluor 568 Azide (Thermo Fisher Scientific) was added to the buffer at a 
1:100 dilution. 
Photography, measurements, cell counts and statistics: 
Microscopy images of retinal sections were captured with the Leica DM5000B microscope with 
epifluorescence and the Leica DC500 digital camera. High resolution confocal images were 
obtained with a Leica SP8 available in The Department of Neuroscience Imaging Facility at The 
Ohio State University. Representative images are modified to have enhanced color, brightness, 
and contrast for improved clarity using Adobe Photoshop. In EdU proliferation assays, a fixed 
region of retina was counted and average numbers of Sox2 and EdU co-labeled cells. The retinal 
region selected for investigation was standardized between treatment and control groups to reduce 
variability and improve reproducibility. 
For quantification of immunofluorescence, densitometry measurements were collected and 
compared between control and treatment conditions. Cell-specific quantifications were taken from 
images with identical staining and exposure times to collect pixel in changes where cell specific 
markers were colocalized. ImagePro 6.2, ImageJ, and Microsoft Excel were used for data and 
calculations respectively. 
For statistical evaluation of differences in treatments, a two-tailed paired T-test was applied for 
intra-individual variability where each biological sample also served as its own control. For two 
treatment groups comparing inter-individual variability, a standard two-tailed unpaired T-test was 
applied. For multivariate analysis, an ANOVA with the associated Tukey Test was used to evaluate 
any significant differences between multiple groups. 
Results 
Single cell RNA sequencing identifies FABPs upregulation in Müller glia during 
reprogramming. 
FABP8 protein expression has been validated in the chick retina. To support MG expression during 
reprogramming and proliferation, we generated a single cell RNA sequencing library analyzing 
the transcriptomic change in MG in response to NMDA damage (Figure 1). Individual cells are 
plotted and clustered in t-stochastic neighbor embedding (tSNE) plots showing transcriptomic 
similarities between cells and highlighting the cell type, library ID/replicate, and heat map 
expression of FABP8 (Figure 1A-B). Of note, MG change their gene expression in response to 
NMDA damage, as shown by the dark green (control MG), forest green (24hr NMDA damage), 
and light green (48-72hr NMDA) clusters (Figure 1A). As part of this reprogramming phase, 
FABP8 can be seen upregulated in MG as high as 64-fold in some cells (Figure 1 C,D). 
Transcriptionally distinct progenitors start forming 48-72hrs after damage (as seen by the neon 
green cluster), and can be highlighted by cell cycle markers Ascl1, Nestin, Rax, PCNA, and Cdk1. 
These replication competent cells also maintain high levels of FABP8 expression, further 
implicating FABP8 in the dedifferentiation and proliferation processes in the retina. 
 
 
FABP8 is expressed during MG reprogramming in the chick retina. 
FABP8 is a novel target in understanding the mechanisms of MG reprogramming, and has not 
been previously identified in the central nervous system in birds. Thus, little is known about its 
potential function in the retina or the formation of MGPCs. To study regeneration in the chick, we 
use a well characterized model of induced MG regeneration through the intravitreal injection of 
N-methyl D-aspartate (NMDA).37 NMDA induces excitotoxic cell death of primarily amacrine 
cells, which in turn induces MG to express retinal progenitor factors and form MGPCs. Of those 
MG that dedifferentiate, a subset of these neurons undergoes cell division primarily 24 to 48 hours 
after damage. Another small subset of these post-mitotic MGPCs will form amacrine and ganglion 
cells.38 Similarly, our studies have found that four consecutive doses of FGF2 is sufficient to 
induce progenitor formation by stimulating muller glia through a mitogen activated protein kinase 
pathway with upregulation of pERK, phospho-cyclicAMP response (pCREB), cFos, and early 
growth response 1 (EGR1).36,39 These two paradigms provide different methods to evaluate MG 
regeneration in the chick retina and how novel targets respond to either facilitate or inhibit MGPC 
formation and neurogenesis. 
 
Using this well characterized response of MG to regenerate in chick, we initially characterize the 
expression of FABP8 in response to NMDA damage (Figure 3). In the undamaged retina, FABP8 
is localized to oligodendrocytes. After damage, the retina dramatically upregulated FABP8 
spanning the outer nuclear layer (ONL) to the nerve fiber layer (NFL), developing a staining 
pattern of MG. MG proliferation is optimal at around 48 hours. This proliferative window is when 
the expression of FABP8 is 
observed to be at maximal 
expression, and was confirmed to 
be localized in MG using Sox2, 
glutamine synthetase, and FABP8 
colocalization. The expression of 
this protein in MG returns to 
physiologic levels 72 hours 
following damage, and MGPCs 
begin to differentiate into new 
neurons. 
 
Inhibition of FABPs reduces the formation of Müller glia derived progenitor cells. 
FABP proteins share common tertiary functions, and have unique binding efficiencies for fatty 
acids.40 To modulate FABP intracellular function, pharmacological inhibitors that interact with the 
binding pocket were developed. One of the first inhibitors identified was for FABP4 called 
BMS309403. Utilizing a fluorescent 8-anilino-8-naphthalene sulfonate (ANS) binding 
displacement assay of palmitic acid, they observed Ki values of <2nM for FABP4, and Ki values 
of 250nM and 350nM for FABP3 & 5 respectively.41 This has been used in-vivo to reduce 
atherosclerosis phenotypes presumably through alterations in fatty acid trafficking in macrophages 
and adipocytes that results in an inhibition of NFkB.42–45  
The apparent physiological benefit of FABP inhibition has inspired additional work to identify 
new inhibitors. Dr. Ojima at Stony Brook university has identified a new inhibitor, SBFI-26 with 
selectivity toward FABP5 with comparable Ki values to BMS309403.
46 Similar to FABP4 
inhibition, there was a change in fatty acid trafficking that resulted in analgesic effects, presumably 
through the polyunsaturated fatty acid anandamide.26,47 Between BMS309403 and SBFI-26, there 
is an opportunity to pharmacologically modify the function of FABP proteins to screen for 
physiologic changes.  
These small molecule drugs will be tested in our chick intraocular injection NMDA paradigms that 
have been previously described.29 After several days of sustained inhibition with NMDA damage, 
there was a significant decrease in MGPCs (Figure. 4). The Edu marking proliferating cells was 
significantly reduced with the administration of BMS309403. This overlap with Sox2 indicated 





The research described here seeks to understand the understudied FABP proteins, and investigate 
their function as a novel target in early reprogramming of MG. FABP proteins are often detected 
on large genomic screens in highly proliferative states, such as cancer and development, but 
relatively little is known about their mechanisms of influencing cell biology. FABP8 is a novel 
target for understanding MG reprogramming and requires innovative approaches to better 
understand their impact on retinal regeneration. 
FABP proteins have been identified in many different contexts, as different isoforms of the FABP 
family have tissue specific expression. Even so, there has been research associating various tissue 
FABPs with progenitor cells and regeneration. FABP1, or liver fatty acid binding protein, is 
upregulated in all states of hepatocyte cell division, and in liver regeneration with 70% resection 
surgeries.48–51 FABP4, found in endothelial cells, caused intimal hyperplasia with AAV 
overexpression vectors leading to vessel stenosis and proteinurea in the heart and kidney 
respectively.52,53 In the developing mouse brain, FABP3, 5, and 7 are invested as a potential target 
to influence dedifferentiation and proliferation.16–18 FABP8 has been a longtime molecular 
identifier of peripheral myelin in mammalian systems, and has been researched on its role in 
structural integrity and axonal regeneration. However, the role of FABP8 in the CNS and retina of 
nonmammalian systems with robust regeneration phenotypes have not been investigated. 
The FABP protein class exhibits high tertiary structure conservation, and may serve redundant 
overlapping functions with the other isoforms. For example, FABP5-/- knockout is a 
developmentally normal mouse with no gross neurological abnormalities.54  This result would limit 
our capacity to interpret different biological models of FABP expression in the retina. Under the 
assumption that different isoforms compensate for important cellular functions, we will expand 
our characterization to other FABP proteins identified in CNS glia and neurons, such as FABP3, 
5, and 7. These proteins have been previously observed in the retina, albeit limitedly, and offer an 
interesting comparison between species where no prior studies have been conducted.55,56 
Our lab will create a plasmid construct for MG specific inducible expression of Cas9 and a FABP8 
specific gRNA to generate a MG FABP8 knockout in one retina. We will create a construct with 
the following design: Tol2-RLBP1-Cas9-P2A-rtTA-Tol2:tetO-gRNA. Tol2 is a transposase 
originally identified in teleost fish that is capable of introducing transposons into the genome of 
vertebrates.57 When integrated at an early stage of development with co-transfection with a CAG-
transposase, all progeny of early retinal progenitors will contain the gene of interest (mosaic retinal 
expression). Retinaldehyde binding protein (RLBP1) promoter is specific to MG in the retina, and 
will drive the expression of Cas9 and the mutant reverse tetracycline transactivator (rtTA). The 
rtTA is inactive until tetracycline administration which binds to the tetracycline operator (tetO) 
and drives transcription of the gRNA. Collectively, this will allow for MG specific knockouts of 
FABP8. Conversely, for simple inducible upregulation of FABP8, we can use a simplified 
construct: RLBP1-rtTA-Tol2:tetO-FABP8. To determine what cells have been transfected, cells 
can be stained for Cas9 or rtTA expression and analyze the effect on MG with the quantification. 
Furthermore, experimentation on these factors in models of mouse retinal damage may give further 
information about the translational potential of these factors in influencing regeneration in a 
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